# US 2021/0030873 A1 · Photosensitizer and derivatives and application thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0030873 A1
- Document ID: US20210030873A1
- Status: Published application
- Kind: A1
- Application number: 16/633,087
- Filed: 2017-11-24
- Published: 2021-02-04
- Earliest claimed: 2017-08-04
- Assignees: Dalian University of Technology; Dalian Chromas Bioscience Co., Ltd
- Applicants: Dalian University of Technology; Dalian Chromas Bioscience Co., Ltd
- Inventors: Xiaojun PENG; Mingle LI; Jiangli FAN; Qichao YAO; Jianjun DU; Saran LONG; Jingyun WANG
- Web page: https://patentgrep.com/patent/US20210030873A1

## CPC

- A61K 41/0057: {Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent}
- A61K 31/405: Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
- A61K 31/4188: condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
- A61K 31/5415: ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
- A61K 31/55: having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K 47/55: the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug
- A61K 47/551: {one of the codrug's components being a vitamin, e.g. niacinamide, vitamin B3, cobalamin, vitamin B12, folate, vitamin A or retinoic acid}
- A61P 35/00: Antineoplastic agents
- C07D 279/18: [b, e]-condensed with two six-membered rings
- C07D 279/36: [b, e]-condensed, at least one with a further condensed benzene ring
- C07D 293/10: condensed with carbocyclic rings or ring systems
- C07D 417/12: linked by a chain containing hetero atoms as chain links
- C07D 421/12: linked by a chain containing hetero atoms as chain links
- C07D 495/04: Ortho-condensed systems
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

A photosensitizer and derivative, application thereof. The photosensitizer has the structure of general formula I, wherein X is S or Se, Y is organic or inorganic ion, R1 and R2 are independently selected from H, alkyl, alkoxy, alkyl amido, alkyl azide and the like; R3 is selected from H, alkyl, alkoxy, amino sulfonyl, hydroxyl, carboxyl and the like, and L1 is a linker selected from —(CH2)n1— or —(CH2CH2O)n2—. The derivatives are molecular medicines with drug molecules of anticancer and chemotherapy or tumor targeting function connected to the said photosensitizer. The photosensitizer has excellent near infrared characteristics and low dark toxicity and is used in the field of photodynamic tumor therapy. The introduction of benzophenothiazine or benzophenoselenazine into derivatives with tumor-targeting function could improve the specific uptake of photosensitizer in tumor tissues. Moreover, clinical anticancer drugs can be introduced into the structure of benzophenothiazine or benzophenoselenazine to achieve the purpose of combining therapy of photodynamic therapy and chemotherapy.

## Claims

### Claim 1

A photosensitizer of formula I:
wherein:
X is S or Se;
Y is selected from the group consisting of halogen ion, ClO4−, PF6−, BF4−, CH3COO− or OTs−;
R1 and R2 are independently selected from the group consisting of H, alkyl, alkoxy, alkylamido, alkyl azide, alkylalkynyl, alkylamino, alkylsulfonyl, alkylhydroxy and alkylcarboxy;
R3 is selected from the group consisting of H, alkyl, alkoxy, aryloxy, morpholinyl, carbonyl, amido, azido, alkynyl, amino, sulfonic acid, hydroxy and carboxy;
L1 is a linking chain selected from —(CH2)m— or —(CH2CH2O)n—;
Wherein the said m is an integer from 5 to 20, and the said n is an integer from 2 to 20.

### Claim 2 (depends on 1)

The photosensitizer of claim 1, wherein the said R1 and R2 are independently selected from the group consisting of H, alkyl group of C1-5, alkoxy group of C1-5, alkyl alkyne group of C2-5, alkyl sulfonyl group of C2-6 and alkyl azide group of C2-6.

### Claim 3 (depends on 1)

The photosensitizer of claim 1, wherein the said R3 is selected from amino, carboxyl, hydroxyl or azido.

### Claim 4 (depends on 1)

The photosensitizer of claim 1, wherein the said m or n are independently 5, 6, 7 or 8.

### Claim 5 (depends on 1)

The photosensitizer of claim 1, wherein the said photosensitizer of formula I is

### Claim 6 (depends on 1)

Application of the photosensitizer of claim 1 for the preparation of an antitumor drug.

### Claim 7 (depends on 1)

A derivative of the photosensitizer of claim 1, having a formula of Formula II:
Wherein R4 is an anticancer and chemotherapy drug molecule or a molecular drug with tumor targeting function.

### Claim 8 (depends on 7)

The photosensitizer derivative of claim 7, wherein the said R4 is selected from the group consisting of a1 to a10:

### Claim 9 (depends on 7)

The photosensitizer derivative of claim 7, are selected from the following compounds:

### Claim 10 (depends on 7)

Application of the photosensitizer derivatives of claim 7 in the preparation of anti-tumor drugs.
